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Background: Ardisia pusilla A. DC., family Myrsinaceae, is a traditional Chinese medicine named Jiu Jie Long with a
variety of pharmacological functions including anti-cancer activities. In this study, we purified a natural triterpenoid
saponin, ardipusilloside I, from Ardisia pusilla, and show that it exhibits inhibitory activities in human mucoepidermoid
carcinoma Mc3 cells. We also investigated the underlying mechanisms of proliferation inhibition that ardipusilloside I
exerts on Mc3 cells.
Methods: MTT test was used to detect cell proliferation. Cell apoptosis was detected by transmission electron
microscopy, Hoechst-33342 staining, DNA fragmentation detection, and flow cytometry. We also used western blot
analysis to detect the potential mechanisms of apoptosis.
Results: Ardipusilloside I affected the viability of Mc3 cells in a dose- and time-dependent manner. The IC50 of
ardipusilloside I was approximately 9.98 μg/ml at 48 h of treatment. Characteristic morphological changes of apoptosis,
including nuclear condensation, boundary aggregation and splitting, and DNA fragmentation, were seen after
treatment with 10 μg/ml ardipusilloside I for 48 h. Western blots demonstrated that ardipusilloside I caused Mc3 cell
death through the induction of apoptosis by downregulation of Bcl-2 protein levels and upregulation of Bax and
caspase-3 protein levels.
Conclusions: Our results revealed that ardipusilloside I could be a new active substance for mucoepidermoid
carcinoma treatment. We demonstrated that the potential mechanism of inhibition might be through the induction of
apoptosis by regulation of Bcl-2 family protein levels. This suggests a further rationale for the development of
ardipusilloside I as an anti-cancer agent.
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Mucoepidermoid carcinoma (MEC) represents one of the
most common salivary gland malignancies, accounting for
as much as 40–52% of all major and minor salivary gland
malignancies [1-3]. To date, chemotherapy and radiother-
apy have been largely employed for palliative treatment of
MEC metastasis but cancer recurrence and poor prognosis
inevitably remain [4]. To explore new active substances or* Correspondence: wxjyh231@fmmu.edu.cn
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reproduction in any medium, provided the orcytotoxic therapies, we have assessed many natural prod-
ucts on MEC cells. In our previous study, we showed that
baicalin exhibited anticancer activity in mucoepidermoid
carcinoma cell line Mc3 by suppressing cell cycle progres-
sion and inducing cell apoptosis [5]. We also found that
ardipusilloside I inhibits the proliferation of Mc3 cells in a
dose- and time-dependent manner [6].
Ardipusilloside I (3-O-[α-L-rhamnopyranosyl-(1→ 2)-β-
D-glucopyranosyl-(1→ 3)-(β-D-glucopyranosyl-(1→ 2))-α-
L-arabinopyranosyl]-cyclamiretin A) (Figure 1) is a natural
triterpenoid saponin isolated from Ardisia pusilla A. DC.
(family Myrsinaceae), a traditional Chinese medicine named
Jiu Jie Long [7]. Laboratory studies on animals and cell linesThis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Chemical structure of ardipusilloside I.
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tion [6], induces cell apoptosis [8,9], and inhibits liver
cancer survival, invasion, and metastasis both in vitro
and in vivo [10]. Xiong and colleagues [8] revealed that
ardipusilloside I inhibited the growth of human glio-
blastoma cells, and induced apoptosis through the FasL/
Fas signaling pathway. However, little is known about
the potential proliferation inhibition mechanism of
ardipusilloside I in Mc3 cells.
In the present study, we analyzed the proliferation inhib-
ition of ardipusilloside I on human mucoepidermoid car-
cinoma Mc3 cells. Our results showed that ardipusilloside
I could induce Mc3 cell apoptosis. Moreover, the potential
mechanism may be associated with the downregulation of




RPMI 1640 culture medium, M199 medium, and fetal bo-
vine serum (FBS) were purchased from GIBCO BRL
(Gibco BRL, Carlsbad, CA). Ardipusilloside I (>98% pure,
free of endotoxin) was collected and stored in our labora-
tory [9], which was dissolved in physiological saline for one
night at −4°C, then the supernatant was passed through a
0.22 μm filter (Millipore, Bedford, MA) for sterilization
and diluted with culture medium to final concentrations
before treatment. In all experiments, the final physiological
saline concentration did not exceed 1‰ (v/v), so as not to
affect cell growth. Polyclonal rabbit anti -caspase −3 (1:500,
Santa Cruz, CA), anti-Bcl-2 (1:500, Santa Cruz, CA), anti-Bax (1:500, Santa Cruz, CA) and anti-β-actin were pur-
chased from Santa Cruz Biotech (CA, USA). 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT) and Hoechst-33342 were purchased from Sigma
(Sigma, USA).
Cell culture
Human mucoepidermoid carcinoma cell line MEC1 and a
highly metastatic human mucoepidermoid carcinoma cell
line Mc3 was obtained and stored in our laboratory [11].
MEC1 and Mc3 cells were cultured in RPMI1640 medium
supplemented with 10% heat-inactivated (56°C) FBS, 100
U/ml penicillin, 100 μg/ml streptomycin. Human normal
parotid acinar cells were obtained by the explant out-
growth technique as reference described [12] from resected
parotid tissue of patients with parotid pleomorphic aden-
oma. The study was approved by the Medical Ethics Com-
mittee of the Fourth Military Medical University, and
informed consent was signed. Parotid acinar cells were cul-
tured in M199 culture medium supplemented with 20%
heat-inactivated (56°C) FBS, 100 U/ml penicillin, 100 μg/
ml streptomycin. Cells were incubated at 37°C in a humidi-
fied atmosphere containing 5% CO2. The cells in exponen-
tial phase were used in this study.
Cell viability assay
The percentage of growth inhibition was determined by
MTT assay [13]. In brief, cells were seeded in 96-well mi-
croplates at a density of 1 × 104 per well and were cultured
for 24 h. After treatment with various concentrations of
Ardipusilloside I for 24 h or 48 h, 0.5 mg/ml MTT was
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humidified atmosphere containing 5% CO2. Subse-
quently, the formazan was dissolved in dimethyl
sulphoxide after the medium was removed. Finally the
optical density (OD) was measured with an ELX800
reader (Bio-Tek Instruments, Inc., Winooski, VT) at
550 nm. The percentage of cell viability was calculated
according to the following formula: (OD value of the
control cells –OD value of the treated cells)/ OD value
of the control cells × 100%. By definition, the viability
of the control cells from the untreated cultures was de-
fined as 100%. The IC 50 value was calculated by SPSS
version 16.0.
S-phase fraction analyses by flow cytometry
The S-phase fraction of Ardipusilloside I treated cells
was analyzed by flow cytometry [14]. In brief, 1 × 106
Mc3 cells were treated with 5.0 μg/ml or 10.0 μg/ml
Ardipusilloside I for 48 h. All attached cells were col-
lected, washed, suspended in ice-cold PBS, fixed in ice-
cold 70% ethanol and stained with 50 μg/ml of PI in the
presence of 25 μg/ml of RNase-A. Then cell sorting was
performed using FACSCalibur System (Becton Dickinson
FACSCalibur, USA) and the histograms were evalu-
ated using CellQuest software. Cellular DNA content
was determined by flow cytometric analysis of PI-labeled
cells.Figure 2 Effects of ardipusilloside I on the cell viability of human mu
MEC1 cells, Mc3 cells and primary cultured parotid acinar cells were treated
and 12.5 μg/ml) for 48 h. (B) MEC1 cells were treated with 5.0, 7.5, 10.0, an
growing Mc3 cells were treated with 10.0 μg/ml of ardipusilloside I for 24 h
μg/ml of ardipusilloside I for various times. Cell viability was determined byMorphological analysis with fluorescence microscopy
To evaluate the apoptotic activity of Ardipusilloside I, we
performed nuclear staining with the DNA-binding dye
Hoechst-33342 [15]. In brief, Mc3 cells (1 × 106 cells in
3 ml) were plated into 6-well plates and treated with
10.0 μg/ml of Ardipusilloside I for 24 h or 48 h. Cells were
collected by centrifugation at 200 × g for 5 min, washed
with ice-cold PBS and then fixed with 2% paraformalde-
hyde in PBS for 10 min at 4°C. Fixed cells were washed
with PBS, incubated with Hoechst-33342 (10 μg/ml) for
15 min in the dark, then placed on slides and observed
under a fluorescence microscope (excitation 352 nm,
emission 461 nm; NIKON TE2000-E). Apoptotic cells
were identified by condensation of chromatin and frag-
mentation of nuclei. Pictures were obtained using a
video camera Q-imaging (Burnaby, BC, Canada).
Ultrastructural studies by transmission electron
microscope (TEM)
Mc3 cells were seeded at the concentration of 1 × 105 cells
in culture flask and incubated for 24 h. Cells were then ex-
posed to 10.0 μg/ ml of Ardipusilloside I for 24 h or 48 h.
The collected cells were harvested and fixed with 2.5%
phosphate-buffered glutaraldehyde at 4°C overnight. The
fixed cells were washed with phosphate buffer, post-fixed
with PBS containing 1% OsO4, dehydrated in graded alco-
hol solutions, and embedded. Ultrathin sections (50 nm)coepidermoid carcinoma Mc3 cells. (A) Exponentially growing of
with various concentrations of ardipusilloside I (0, 2.5, 5.0,7.5, 10.0,
d 12.5 μg/ml of ardipusilloside I for various times. (C) Exponentially
and 48 h. (D) Mc3 cells were treated with 5.0, 7.5, 10.0, and 12.5
the MTT assay. Each bar represents the mean ± SE (n = 3).
Figure 3 S-phase fraction in ardipusilloside I-treated and control cells. (A) Control. (B) 5.0 μg/ml ardipusilloside I. (C) 10.0 μg/ml
ardipusilloside I. (D) A significant fraction of cells were found in S-phase when treated with 5.0 μg/ml or 10.0 μg/ml ardipusilloside I for 48 h
compared with control cells. *P = 0.0026, **P = 0.0002.
Figure 4 Chromatin condensation and nuclear fragmentation typical for apoptosis induction were visualized by fluorescence
microscopy of Hoechst 33342-stained and TEM. After treatment with 10 μg/ml of Ardipusilloside I for 24 h (B) and 48 h (C) or without
(A) Ardipusilloside I, Mc3 cells were incubated with Hoechst 33342 at a final concentration of 1.5 μM for 10 min. Red arrows show the
characteristic morphological changes of apoptosis, including nuclear condensation, boundary aggregation and splitting, and DNA fragmentation.
Magnification 400×. (D) Mc3 cells in the control group had a normal structure with a large and round nucleus, uniform chromatin density, and
clear nucleolus. Magnification 6000×. (E) Mc3 cells treated with 10.0 μg/ ml of ardipusilloside I for 24 h showed chromatin condensation.
Magnification 6000×. (F) Mc3 cells treated with 10.0 μg/ ml of ardipusilloside I for 48 h showed typical cell shrinkage, chromatin condensation,
and membrane blebbing. Magnification 6000 ×.
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Figure 5 Nuclear apoptosis induced by ardipusilloside I. Mc3
cells were cultured with either diluent (control, line 1) or
ardipusilloside I (2.5 μg/ml, line 2 and 10 μg/ml, line 3) for 48 h,
harvested, and DNA was precipitated and electrophoresed on 1.5%
agarose gel. M is the marker.
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morphology was observed by TEM (JEOL, Japan).
DNA fragmentation detection
The induction of apoptosis by Ardipusilloside I was also
tested by the formation of DNA ladder fragments [16]. In
brief, Mc3 cells (5 × 106/sample, both attached and detached
cells) cultured with Ardipusilloside I (2.5,5.0,10.0 μg/ ml) or
without Ardipusilloside I at 37°C for 48 h were harvested
and suspended in 1 ml medium. According to the manufac-
turer’s protocol, the total DNA was isolated by using a
DNA extraction kit (TIANGEN BIOTECH, Beijing, China)
and electrophoresed on a 1.5% agarose gel containing
0.1 mg/ml ethidium bromide. Ladder formation of oligo-
nucleosomal DNA was photographed under transmitted
ultraviolet light.
Apoptosis analysis by flow cytometry
Apoptosis was measured using flow cytometry to quantify
the levels of detectable phosphatidylserine on the outer
membrane of apoptotic cells. In brief, Mc3 cells treated
with or without Ardipusilloside I for 24 h or 48 h were
collected by trypsinization and washed twice with PBS,
then fixed in ice-cold 70% (v/v) ethanol at 4°C. After cen-
trifugation, the cell pellets were resuspended in a 500 μl
binding buffer solution (10 mM HEPES–NaOH, pH 7.4,
140 mM NaCl, 2.5 mM CaCl2). Then, 5 μl of Annexin V-
FITC (BD Pharmingen, USA) and 2 μl of PI solutions were
added and the mixtures were further incubated in the dark
for 30 min at room temperature. The Annexin V-FITC
and PI fluorescence of cultured cells were analyzed by flow
cytometry (Becton Dickinson FACSCalibur, USA). For
each sample, the fluorescence of 10,000 cells was gated
and counted. The percentage of cells in the upper right
(late apoptotic cells), upper left (necrotic cells), lower right
(early apoptotic cells) and lower left (viable cells) portion
of the scatter plot was calculated for comparison.
Western blot analysis for apoptosis related proteins
The Mc3 cells were treated with various concentration of
Ardipusilloside I (0, 2.5, 5.0, 10.0 μg/ml) for 48 h, respect-
ively. Protein extracts of cells were prepared by lysing cells
in RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS, 50 mM Tris–HCl, pH 8), 10 mM
EDTA and 1 mM PMSF (Sigma, USA) for 30 min at 4°C.
Samples were then centrifuged 15 min at 15,000 × g. The
protein concentration on the supernatant was determined
by BCA protein Assay. For each sample, equal amounts of
lysates were loaded on a 9.0% SDS polyacrylamide gel
electrophoresis, and transferred to a nitrocellulose mem-
brane (0.22 lm, Pall, NY, USA). Membranes were blocked
for 2 h at the RT with blocking buffer (TBS containing
0.05% Tween 20 (Sigma, USA) and 5% non-fat milk (w/v)).
Then, the membranes were incubated overnight at 4°C.Primary antibodies (incubated for 1 h at room temperature)
were: rabbit polyclonal anti-Bcl-2, anti-caspase-3 and anti-
Bax. They were diluted 1:200, except anti-β-actin (1:1000).
Thereafter, the membranes were washed thrice for 10 min
with TBS buffer containing 0.05% Tween-20, incubated
with antirabbit secondary antibodies (1:3000) for 1 h at RT,
and then developed by an ECL system according to the
manufacturer’s instructions (Amersham, USA).Statistical analysis
All data and results were confirmed by at least three inde-
pendent experiments and were expressed as means ±
standard error of the mean (SE). Statistical analysis was
performed using students’t test to compare data in differ-
ent groups. Calculations were carried out using SPSS ver-
sion 16.0 and P values less than 0.05 were considered
statistically significant.
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Ardipusilloside I inhibited the proliferation of MEC1 cells
and Mc3 cells but did not affect the viability of primary
cultured parotid acinar cells
The effect of ardipusilloside I on the viability of Mc3 cell,
another mucoepidermoid carcinoma cell line MEC1 cells
and primary cultured parotid acinar cells were assessed by
the MTT assay. The results showed that low dose of ardi-
pusilloside I did not affect the viability of primary cultured
parotid acinar cells, and 12.5 μg/ml of ardipusilloside I for
48 h showed slight cytotoxicity (Figure 2A). The number of
viable Mc3 cells and MEC1 cells decreased significantly in
a dose- and time-dependent manner compared to vehicle
control cells (Figure 2A and B). The viability of Mc3 cells
treated with 7.5 μg/ml and 12.5 μg/ml of ardipusilloside IFigure 6 Ardipusilloside I induces apoptosis of the Mc3 cell line. (A) M
10.0 μg/ml ardipusilloside I for 24 h. (C) Mc3 cells were treated with 10.0 μ
(PI) staining were analyzed by FACScan. Q3: viable cells; Q4: early apoptotic
treatment greatly enhanced the apoptosis of Mc3 cells (*P < 0.0001, **P < 0for 48 h decreased to 74.626 ± 0.006% and 24.984 ± 0.095%,
and the IC50 value was 9.98 μg/ml. (Figure 2C and D).
Measurement of the DNA content revealed a significantly
lower S-phase fraction in cells treated with 5.0 μg/ml or
10.0 μg/ml ardipusilloside I for 48 h compared with control
cells (Figure 3).Effects of ardipusilloside I on cell nuclear morphology
and DNA fragmentation
To assess whether ardipusilloside I induces apoptosis of
Mc3 cells at the single cell level, fluorescence microscopy,
electron microscopy, and DNA ladder formation assays
were used to detect the cellular nuclear morphology and
DNA fragmentation.c3 cells were treated with NS. (B) Mc3 cells were treated with
g/ml ardipusilloside I for 48 h. Annexin binding and propidium iodide
cells; Q2: late apoptotic cells. (D) 10.0 μg/ml ardipusilloside I
.0001).
Figure 7 Effect of ardipusilloside I on the expression of apoptotic
proteins. Mc3 cells were exposed to various concentrations (2.5 μg/ml,
5 μg/ml, and 10 μg/ml) of ardipusilloside I for 48 h and the levels of
Bcl-2, Bax, and caspase-3 were measured by Western blot analysis.
Increased expression of Bax and caspase-3 and a decrease of Bcl-2
were observed. β-Actin was used as an internal loading control.
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cells possessed marked morphological changes in a dose-
dependent manner after exposure to ardipusilloside I. Con-
trol Mc3 cells had normal morphology with round and
homogeneous nuclei (Figure 4A). After treatment with
10 μg/ml of ardipusilloside I for 24 h or 48 h, alterations in
the structure, size, and shape of the cell nuclei were de-
tected. Condensed chromatin, cell shrinkage, and nuclear
fragmentation as well as the formation of apoptotic bodies
were observed (Figure 4B,C). Furthermore, another ex-
periment using electron microscopy clearly showed char-
acteristic apoptotic cells after exposure to 10 μg/ml of
ardipusilloside I for 24 h or 48 h. Compared with the nor-
mal intracellular morphology of the control cells, after
24 h treatment, condensation of nuclei were observed
(Figure 4E). And with 48 h treatment, apoptotic Mc3 cells
displayed the distinctive morphological changes of apop-
tosis, such as condensation of nuclei and the cytoplasm
and blebbing of cytoplasmic membranes (Figure 4F).
It is well accepted that DNA ladder formation is highly
specific for apoptotic cell death. In Mc3 cells without
treatment, no DNA nucleosome ladder was detected
(Figure 5, lane 1). In contrast, the typical formation of
DNA nucleosome ladders was obvious after treatment
with ardipusilloside I, indicating that 10 μg/ml of ardi-
pusilloside induced apoptosis significantly (Figure 5,
lane 3).
Ardipusilloside I induces apoptosis in Mc3 cells
The nuclear morphology of treated cells suggested that
ardipusilloside I triggered apoptosis. To confirm that
ardipusilloside I induced apoptosis in Mc3 cells, an
annexin V binding and PI dual staining assay, which
measures another feature of apoptosis, was conducted.
We found that 10.0 μg/ml ardipusilloside I treatment for
24 h or 48 h greatly enhanced the apoptosis of Mc3 cells
with an apoptotic cell ratio of 86.27 ± 1.86% in the 48 h
treated group and 11.63 ± 1.09% in the control group
(Figure 6) (P < 0.0001).
Involvement of caspases-3 and Bcl-2/Bax in
ardipusilloside I-induced apoptosis
To determine the underlying mechanism by which
ardipusilloside I induced apoptosis in Mc3 cells, we
measured the expression of cell apoptosis molecules
caspase-3, Bax, and apoptosis inhibitory protein Bcl-2
(Figure 7). Bcl-2 protein expression was reduced follow-
ing ardipusilloside I treatment (0, 2.5, 5.0, 10.0 μg/ml for
48 h), while caspase-3 and Bax proteins were increased.
Discussion
Ardipusilloside I, a natural saponin, has been shown to
induce apoptosis in human cervical adenocarcinoma
cells, Lewis pulmonary carcinoma, hepatocarcinoma,U87MG cells, and NCI-H460 cells [8,9,17]. Our recent
data have also demonstrated that ardipusilloside I signifi-
cantly decreases the viability of human mucoepidermoid
carcinoma Mc3 cells in a dose- and time-dependent
manner [6]. In order to explore the potential mechanism,
the dose 10.0 μg/ml treatment for 48 h which was closed
to its IC50 was selected as the main experimental index.
To test whether ardipusilloside I induce apoptosis in
human mucoepidermoid carcinoma, cell viability and in-
hibition were evaluated in Mc3 cells. Morphological
studies revealed that Mc3 cells treated with ardipusillo-
side I displayed obvious apoptotic characteristics such as
shrinkage and chromatin margination. Ardipusilloside I
induced the apoptosis of Mc3 cells, as detected by
annexin V binding and PI dual staining. Apoptosis was
confirmed by TEM and nucleosomal DNA ladders, the
hallmarks of apoptosis [18]. Our data on Mc3 cells are
similar to previous studies in other tumor cell lines in
which ardipusilloside I induced tumor cell death with
apoptosis [8,9,17]. Therefore, ardipusilloside I may be a
tumor cell apoptosis inducer.
As ardipusilloside I-induced apoptosis is well docu-
mented through analysis of various cancer cells, recent
studies investigated the underlying mechanism of its
apoptosis action [8,9,17]. Xiong et al. [8] found that
ardipusilloside I enhanced expression of Fas and its lig-
and FasL in glioblastoma cells. Moreover, they indicated
that the ardipusilloside I-induced apoptosis in glioblast-
oma cells depends on the enhanced expression of the
FasL/Fas-signaling pathway and is independent of the
activation of caspase-8. However, our result showed that
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expression was decreased after ardipusilloside I treat-
ment. Meanwhile, caspase-3, the downstream caspase,
was overexpressed.
Apoptosis, or programmed cell death, is one of the
most important processes regulating the balance of cell
growth and cell death, and is preferred to necrosis as a
mechanism of cancer cell death [19-21]. Resistance to
apoptosis is one of the hallmarks of human cancers.
The Bcl-2 family of proteins plays an important role in
regulating the mitochondrial or intrinsic apoptotic
pathway [22,23]. The apoptotic inhibitory Bcl-2 protein
is on the cytoplasmic face of the mitochondrial outer
membrane, endoplasmic reticulum, and nuclear enve-
lope, and may participate in mitochondrial permeability
transitions [24]. In contrast, Bax is a proapoptotic regu-
lator [25]. Bcl-2 and Bax can be expressed in harmony,
and this plays an important role in cell growth and cell
death. Cells are active when Bcl-2 is overexpressed
while cells die if Bax is overexpressed [26]. It has been
reported that overexpression of Bcl-2, which is caused
by chromosomal translocation of the Bcl-2 oncogene
into the immunoglobulin heavy chain gene locus, is a
characteristic feature of human follicular lymphoma
[27]. Moreover, the inactivation of the proapoptotic Bax
gene resulted by somatic mutations has been identified
in certain solid tumors and hematological malignancies.
For example, single nucleotide substitutions or frame-
shift mutations of the Bax gene can occur in mismatch
repair-deficient colon cancers or hematopoietic malig-
nancies [28,29].
In this study, we found that ardipusilloside I could
markedly reduce the viability of Mc3 cells. We also
found that the proapoptotic regulator protein Bax was
overexpressed, and anti-apoptotic Bcl-2 protein expres-
sion was reduced following ardipusilloside I treatment.
Meanwhile, caspase-3, the downstream caspase, was in-
creased. However, there are still some limitations in this
present study. First, because it was hard to make pri-
mary cultures and subcultures of normal mucoepider-
moid acinar cells, the data of ardipusilloside I on these
cells are not included in this study. However, Xiong and
colleagues tested the effect of ardipusilloside I on human
glioblastoma U87MG cells and normal SVGp12 astro-
cytes [8]. They found that ardipusilloside I did not affect
the viability of SVGp12 astrocytes with a dose of
15 μmol/L, while glioblastoma cells were significantly
decreased. Second, caspase-3 and PARP are viewed as
key enforcers of apoptosis, and activated caspase-3 can
further decompose its critical downstream substrate
PARP and ultimately lead to apoptosis [30,31]. Unfortu-
nately, we cannot determine this from this data, though
the upregulation of Bax and caspase-3 protein levels
were studied.Conclusion
In conclusion, we demonstrated that ardipusilloside I
causes Mc3 cell death through the induction of apoptosis.
Its pharmacological mechanism may be associated with
the downregulation of Bcl-2 protein levels and upregula-
tion of Bax and caspase-3 protein levels. Our present re-
sults provide further rationale for the development of
ardipusilloside I as a clinically effective and safe anticancer
drug to treat mucoepidermoid carcinoma patients.
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